Default object view. Click to create a custom template, Node ID: 179689, Object ID: 107419

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX...

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

No relation

Yes

No relation

No

07/02/2017 5:28 pm

No